Cargando…
The bromodomain inhibitor IBET-151 attenuates vismodegib-resistant esophageal adenocarcinoma growth through reduction of GLI signaling
The Hedgehog/GLI (HH/GLI) signaling pathway plays a critical role in human oncogenesis. Unfortunately, the clinical use of HH inhibitor(s) has been associated with serious adverse effects and mutation-related drug resistance. Since the efficacy of SMO (Smoothened) and GLI inhibitors is limited in cl...
Autores principales: | Alvarez-Trotta, Annamil, Wang, Zhiqiang, Shersher, Elena, Li, Bin, Long, Jun, Lohse, Ines, Wahlestedt, Claes, El-Rifai, Wael, Robbins, David J., Capobianco, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443367/ https://www.ncbi.nlm.nih.gov/pubmed/32913560 http://dx.doi.org/10.18632/oncotarget.27699 |
Ejemplares similares
-
BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation
por: Kerscher, Bernhard, et al.
Publicado: (2019) -
Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
por: Lohse, Ines, et al.
Publicado: (2018) -
Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells
por: Kang, Sun Kyoung, et al.
Publicado: (2020) -
NACK and INTEGRATOR act coordinately to activate Notch-mediated transcription in tumorigenesis
por: Shersher, Elena, et al.
Publicado: (2021) -
A novel chemical attack on Notch-mediated transcription by targeting the NACK ATPase
por: Diluvio, Giulia, et al.
Publicado: (2023)